Sam Fazeli

speaker

906 appearances 5 recordings 1 series first heard Oct 2025 last heard 31 Mar

Sam Fazeli’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 5 in all, peaking in Mar 2026 with 2.

Appearances

newest first · ▶ plays the moment

Vanguards of Healthcare by Bloomberg Intelligence · Fosun Pharma’s Drive Beyond China · 17 Nov 2025 podcast

But people are scared of the speed with which China has evolved.

I know that in bio perhaps there's some more catching up to do, but if you look at some of the analysis people do in the materials, engineering, I mean, China leads.

It's not a question of how much longer do they have before they catch up.

It's others that have to catch up.

So we shouldn't punish hard work, right?

Thank you very much, Yingli.

It's been fantastic.

And I really look forward to seeing you soon.

And thank you for joining us.

Vanguards of Healthcare by Bloomberg Intelligence · Recapping ESMO, Inside AstraZeneca’s Bold Bet on Antibody Drug Conjugates · 27 Oct 2025 podcast

Welcome to another episode of the Vanguards of Healthcare podcast.

I'm Sam Fazelli, Senior Pharmaceutical Analyst and Head of Global Industries Research at Bloomberg Intelligence.

And this is a podcast where we get the opportunity to speak with the leading figures in the healthcare industry.

And today I'm very happy to say that we have Susan Goldbraith from AstraZeneca again.

And now after the ESMO, the European Society for Medical Oncology Conference, to discuss some of the data.

And of course, again, AstraZeneca was one of the leading companies at the conference in terms of key data sets being reported.

And we did one after ASCO, which went really well.

And I really appreciate the time that Susan offers us.

Susan, of course, everybody knows, Executive Vice President of Oncology R&D at AstraZeneca, which is, if not the leading, one of the top leading oncology plays in the pharmaceutical sector.

So Susan, just before we start, I wondered if you wanted to say any introductory words or we can go straight to first question on breast cancer.

So that's a perfect lead into our first conversation, talking about early intervention with an ADC.

Showing 701–720 of 906 · page 36 of 46